Question 1

What is the main difference between CT-388 and Retatrutide?

Accepted Answer

Both CT-388 and Retatrutide are categorized under Metabolic, but they differ in evidence strength. CT-388 has Moderate evidence (8 sources), while Retatrutide has High evidence (124 sources).

Question 2

Which has more clinical evidence, CT-388 or Retatrutide?

Accepted Answer

Retatrutide has more clinical evidence with 15 human studies compared to 6 for CT-388. Overall, Retatrutide has High evidence strength while CT-388 has Moderate.

Question 3

Are CT-388 and Retatrutide FDA approved?

Accepted Answer

CT-388 has moderate clinical evidence from human studies, though its regulatory status varies. Retatrutide has high-level clinical evidence, indicating FDA-approved or Phase 3 validated status. Always verify current regulatory status with official sources.

Question 4

Can CT-388 and Retatrutide be combined?

Accepted Answer

There is no published research on combining CT-388 and Retatrutide. The safety and efficacy of any combination is unknown without clinical data.

CT-388 vs Retatrutide

CT-388

Retatrutide

Overview

Evidence Comparison

Key Differences

Summary

View Full Dossiers

Stay Updated on Peptide Comparisons

Aspect	CT-388	Retatrutide
Evidence Level	Moderate	High
Human Studies	6	15
Preclinical Studies	2	6
Total Sources	8	124

Aspect	CT-388	Retatrutide
Category	Metabolic	Metabolic
Evidence Strength	Moderate	High
Total Sources	8	124
Human Studies	6	15